Skip to content

About
Advanced Therapies
- Aseptic Fill & Finish
- mRNA – ADCs
Specialty Orals
- Psychedelics/Medicinal Cannabis
- Oral Finished Dose
API & Intermediates
- Active Pharmaceutical Ingredients
Investors
News
Contact

News

Home » News » IDT – Whistleblower Policy_181219_FINAL

IDT – Whistleblower Policy_181219_FINAL

December 18, 2019 | News

The policy can be viewed here:

Posts navigation

← IDT Appendix_03Z G Kaufman 2019

IDT – Whistleblower Policy →

Recent Posts

Herald Sun 6 May 2024 – Cancer Therapy Lab Plan
Taylor Collison Analyst Report 21 April – IDT sterile license update
Business Update – COVID-19 Stage 4
ASX ann_CFO Co Sec Appointment_16Jun20_final
ASX ann_Cann_EU UK Export Supply 26May20

Archives

June 2024
April 2023
August 2020
June 2020
May 2020
April 2020
February 2020
December 2019
November 2019
October 2019
August 2019
May 2019
January 2019

Site map
Privacy Policy
Regulatory Compliance
Contact us

© 2023 IDT Australia. All Rights Reserved.